1. Home
  2. MDWD vs SPIR Comparison

MDWD vs SPIR Comparison

Compare MDWD & SPIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDWD
  • SPIR
  • Stock Information
  • Founded
  • MDWD 2000
  • SPIR 2012
  • Country
  • MDWD Israel
  • SPIR United States
  • Employees
  • MDWD N/A
  • SPIR N/A
  • Industry
  • MDWD Medicinal Chemicals and Botanical Products
  • SPIR Telecommunications Equipment
  • Sector
  • MDWD Health Care
  • SPIR Consumer Discretionary
  • Exchange
  • MDWD Nasdaq
  • SPIR Nasdaq
  • Market Cap
  • MDWD 179.1M
  • SPIR 201.1M
  • IPO Year
  • MDWD 2014
  • SPIR N/A
  • Fundamental
  • Price
  • MDWD $17.57
  • SPIR $10.56
  • Analyst Decision
  • MDWD Strong Buy
  • SPIR Buy
  • Analyst Count
  • MDWD 1
  • SPIR 6
  • Target Price
  • MDWD $28.00
  • SPIR $14.20
  • AVG Volume (30 Days)
  • MDWD 54.1K
  • SPIR 337.5K
  • Earning Date
  • MDWD 08-14-2024
  • SPIR 11-06-2024
  • Dividend Yield
  • MDWD N/A
  • SPIR N/A
  • EPS Growth
  • MDWD N/A
  • SPIR N/A
  • EPS
  • MDWD N/A
  • SPIR N/A
  • Revenue
  • MDWD $20,141,000.00
  • SPIR $107,223,000.00
  • Revenue This Year
  • MDWD $30.16
  • SPIR $19.74
  • Revenue Next Year
  • MDWD $18.44
  • SPIR $22.65
  • P/E Ratio
  • MDWD N/A
  • SPIR N/A
  • Revenue Growth
  • MDWD N/A
  • SPIR 24.15
  • 52 Week Low
  • MDWD $7.45
  • SPIR $3.27
  • 52 Week High
  • MDWD $24.00
  • SPIR $19.40
  • Technical
  • Relative Strength Index (RSI)
  • MDWD 47.75
  • SPIR 61.31
  • Support Level
  • MDWD $17.50
  • SPIR $7.87
  • Resistance Level
  • MDWD $18.77
  • SPIR $8.60
  • Average True Range (ATR)
  • MDWD 0.84
  • SPIR 0.66
  • MACD
  • MDWD 0.05
  • SPIR 0.38
  • Stochastic Oscillator
  • MDWD 52.68
  • SPIR 91.79

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About SPIR Spire Global Inc.

Spire Global Inc is a provider of space-based data, analytics, and Space Services, offering datasets and powerful insights about Earth from the ultimate vantage point of space so that organizations can make decisions with confidence, accuracy, and speed. It generates revenue from four solutions: Maritime, Aviation, Weather, and Space Services. It offers the following three data solutions to customers; Maritime-precise space-based data used for accurate ship monitoring, ship safety, and route optimization, Aviation-precise space-based data used for accurate aircraft monitoring, aircraft safety, and route optimization, and Weather-precise space-based data used for accurate weather forecasting.

Share on Social Networks: